PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24… — Class II drug recall D-0341-2018
Terminated recall by PD-Rx Pharmaceuticals, Inc., reported 2018-02-07, distributed nationwide. CGMP deviations.
| Recall number | D-0341-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, United States |
| Recall initiated | 2018-01-25 |
| Classified | 2018-02-08 |
| Reported by FDA | 2018-02-07 |
| Terminated | 2020-05-07 |
| Distributed | Nationwide (US) |
| Quantity | 7,174 bottles |
| Reason classes | cgmp |
| NDC | 55289-0673-24, 55289-0673-30, 55289-0673-50, 55289-0673-60 |
| Lot numbers | A17D63, A17F21, B17A87, B17D71, C17C58, D17E92, E17A18, E17A51, F17B87, J16D13, K16E01, K16E92, L16B59 |
| Expiration dates | 2018-01-31, 2018-05-31 |
Product
PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30 tablets NDC 55289-673-30; c) 50 tablets NDC 55289-673-50; d) 60 tablets NDC 55289-673-60
Reason for recall
CGMP deviations.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0341-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.